CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE STUDY.

Dr. Ravella Ranjith, Dr. Nishitha Shetty, Dr. Prasanth Ym, Dr. Dinesh Shet

Abstract


AIMS: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and is apparent as the main cause of death
in patients with liver cirrhosis or chronic hepatitis B or C virus infection. It is emerging as a major leading cause of cancer
mortality. In India, the mean incidence of Hepatocellular carcinoma is 2.77% for males and 1.38% for females based on
the population registry. Our study aims to assess the clinico-etiological profile of HCC at a tertiary hospital in India.
METHODS AND MATERIAL: Cross-sectional, observational and hospital-based retrospective study. Patients
diagnosed as HCC from Jan 2014 to Feb 2019, registered in Hepatocellular Cancer Registry and admitted to the hospital,
were reviewed. Clinical, biochemical, serological and radiological details were noted from case records and analysed.
Out of the total 70 Patients, 57 patients had radiological or pathological evidence of HCC. Out of 57 patients, 53 of them
had radiologically confirmed the diagnosis and 44 of them had histopathological report confirmative of HCC.
RESULTS:Age wise, out of 57 HCC patients 45 are males, 12 are females. Median age group is 60 years. The predominant
complaint among HCC patients is abdominal pain/discomfort in 56.75% followed by abdominal distension in 40.54%.53
patients out of 57 patients have undergone HIV/HBsAg/Anti HCV serology testing. 5 out of 53 patients screened for
HBsAg antigen were positive and 2 patients were anti-HCV antibody positive. Alpha-fetoprotein levels were available in
45 patients, out of which 12 (26.6%) patients had normal levels of alpha-fetoprotein and 20(44.4%) patients have in the
diagnostic range of more than 400ng/ml. Patients were classified according to okuda staging and most of the patients
belong to Okuda stage I (48.07%). Most of the patients were started on Sorafenib 200mg once daily dose and titrated
according to tolerance.
CONCLUSIONS: This data on HCC provides information about tumour characteristics and possible associated risk
factors. Study results show that alcohol consumption (40%) is the commonest underlying etiological factor for HCC
followed by Hep B (9.43%) and Hep C (3.77%). Hepatitis B positivity in this study is lower than observed in various other
studies done in India.


Keywords


Hcc, Hepatocellular Carcinoma, Hepatitis B, Hepatitis C, Alcohol Consumption, Okuda Staging, Alpha-fetoprotein.

Full Text:

PDF

References


Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001 Oct:153-6.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-424.

Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004 Nov 1;127(5):S5-16.

Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999 Sep 24;83(1):18-29.

Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, Digumarti R, Sebastian P, Borthakur BB, Kalwar A, Kapoor S. The growing burden of cancer in India: epidemiology and social context. The Lancet Oncology. 2014 May 1;15(6):e205-12.

Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998 Jan;27(1):273-8.

Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011 Mar 1;53(3):1020-2.

Welzel TM, Graubard BI, Quraishi S, Zeuzem S, Davila JA, El-Serag HB, McGlynn KA. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. The American journal of gastroenterology. 2013 Aug;108(8):1314.

Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. Journal of gastroenterology and hepatology. 2001 Jun;16(6):666-73.

Paul SB, Chalamalasetty SB, Vishnubhatla S, Madan K, Gamanagatti SR, Batra Y, Gupta SD, Panda SK, Acharya SK. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77(3-4):162-71.

Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM: An International Journal of Medicine. 2008 Apr 24;101(6):479-85.


Refbacks

  • There are currently no refbacks.